It may be a prognostic marker in neuroendocrine tumors, correlates with survival in colon cancer, paragangliomas.[24,25] PCSK2 encodes a protein-degrading enzyme responsible for activating inactive prohormones into active peptides. This evidence concerns the gene PCSK2 and colonic neoplasm.